SCHEMBL5083168

SCHEMBL5083168

CN1CCCCC1CCOC(c1ccccc1)c1ccc(Br)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 2/20 0.49
HTR1A P08908 2/20 0.49
ADRA2A P08913 2/20 0.49
CHRM1 P11229 2/20 0.49
DRD1 P21728 2/20 0.49
TBXA2R P21731 2/20 0.49
SLC6A2 P23975 2/20 0.49
SLC6A4 P31645 2/20 0.49
OPRM1 P35372 2/20 0.49
DRD3 P35462 2/20 0.49
SLC6A3 Q01959 2/20 0.49
LMNA P02545 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
KCNH2 Q12809 2/20 0.46
ESRRB O95718 1/20 0.46
ESR1 P03372 1/20 0.46
ESRRA P11474 1/20 0.46
ESRRG P62508 1/20 0.46
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4912551 0.81 KDM5A (0.42) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11484640 0.79 CHRNB2 (0.50) ADRA2A
SCHEMBL4905667 0.78 KDM5A (0.43) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11469630 0.77 KDM4E (0.56)
SCHEMBL11447668 0.76 ESRRG (0.59) KCNH2ESRRBESR1ESRRAESRRG
SCHEMBL15871644 0.75 ADRA2A (0.56) ADRA2ACHRM1CYP1A2CYP2D6HIF1A
SCHEMBL4909463 0.74 CYP3A4 (0.44) CHRM2HTR1AADRA2ACHRM1DRD1
SCHEMBL11448134 0.74 SLC6A4 (0.47) SLC6A4KCNH2ESRRBESR1ESRRA
SCHEMBL11448915 0.74 SLC2A1 (0.58) ADRA2AKCNH2ESRRBESR1ESRRA
SCHEMBL11448032 0.72 ESRRG (0.61) KCNH2ESRRBESR1ESRRAESRRG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008133884-A2 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS COMBINATORX, INCORPORATED (US) 2008-11-06 WO disclosed